Fractyl Health's market research reveals that about one-third of GLP-1 users prefer a one-time endoscopic procedure over ongoing medication to maintain weight loss after stopping GLP-1 drugs. With an estimated one million U.S. patients discontinuing GLP-1 each month and facing weight regain, the investigational Revita procedure offers a promising alternative. Early clinical data shows Revita helps retain 80% of weight loss at six months post-GLP-1, supporting its potential commercial success. The company plans to report 12-month results in early 2027 and is preparing for future commercialization and regulatory steps.
Fractyl Health's research on a one-time procedural approach to post-GLP-1 weight maintenance provides context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 29, 2026 17:11 WIB: Of 150 priced health-sector US stocks, 86 rose and 57 fell. Vertex Pharmaceuticals (VRTX) traded at USD 544.88 with a 1-day gain of 2.87% and a typical hold time of 122 days, contrasting with Novartis (NVS) at USD 160.09, up 2.57% with a shorter hold time of 84 days, while Brookdale Senior Living (BKD) was priced at USD 10.22, gaining 2.40% and held typically for just 14 days.
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...
Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...
Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...
